JANICE NICOLE CORMIER to Quality of Life
This is a "connection" page, showing publications JANICE NICOLE CORMIER has written about Quality of Life.
Connection Strength
1.292
-
Reducing patient burden to the FACT-Melanoma quality-of-life questionnaire. Melanoma Res. 2012 Apr; 22(2):158-63.
Score: 0.147
-
Health-related quality of life in patients with melanoma: overview of instruments and outcomes. Dermatol Clin. 2012 Apr; 30(2):245-54, viii.
Score: 0.145
-
Mapping FACT-melanoma quality-of-life scores to EQ-5D health utility weights. Value Health. 2011 Sep-Oct; 14(6):900-6.
Score: 0.140
-
Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health (Lond). 2010 May; 6(3):399-406.
Score: 0.129
-
Minimal limb volume change has a significant impact on breast cancer survivors. Lymphology. 2009 Dec; 42(4):161-75.
Score: 0.125
-
Evaluating minimal important differences for the FACT-Melanoma quality of life questionnaire. Value Health. 2009 Nov-Dec; 12(8):1144-50.
Score: 0.122
-
Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire. Cancer. 2008 May 15; 112(10):2249-57.
Score: 0.113
-
Measuring quality of life in patients with melanoma: development of the FACT-melanoma subscale. J Support Oncol. 2005 Mar-Apr; 3(2):139-45.
Score: 0.090
-
Functional outcome after treatment of lower extremity soft tissue sarcoma: what should we tell our patients? Ann Surg Oncol. 2004 May; 11(5):453-4.
Score: 0.085
-
Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema. Eur J Cancer Care (Engl). 2015 Sep; 24(5):724-33.
Score: 0.045
-
Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology. 2013 Jul; 22(7):1466-84.
Score: 0.038
-
Frequent and early death limits quality of life assessment in patients with advanced malignancies evaluated for palliative surgical intervention. Ann Surg Oncol. 2012 Nov; 19(12):3651-8.
Score: 0.037
-
Assessment of patient-reported outcomes in patients with melanoma. Surg Oncol Clin N Am. 2011 Jan; 20(1):201-13.
Score: 0.034
-
Cost effectiveness of adjuvant interferon in node-positive melanoma. J Clin Oncol. 2007 Jun 10; 25(17):2442-8.
Score: 0.026
-
Health-related quality of life among patients with metastatic melanoma: results from an international phase 2 multicenter study. Melanoma Res. 2012 Feb; 22(1):54-62.
Score: 0.009
-
Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol. 2007 Aug; 14(8):2309-18.
Score: 0.007